1. Home
  2. NXRT vs PAHC Comparison

NXRT vs PAHC Comparison

Compare NXRT & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXRT
  • PAHC
  • Stock Information
  • Founded
  • NXRT 2014
  • PAHC 1946
  • Country
  • NXRT United States
  • PAHC United States
  • Employees
  • NXRT N/A
  • PAHC N/A
  • Industry
  • NXRT Real Estate Investment Trusts
  • PAHC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXRT Real Estate
  • PAHC Health Care
  • Exchange
  • NXRT Nasdaq
  • PAHC Nasdaq
  • Market Cap
  • NXRT 859.4M
  • PAHC 968.3M
  • IPO Year
  • NXRT N/A
  • PAHC 2014
  • Fundamental
  • Price
  • NXRT $34.89
  • PAHC $29.65
  • Analyst Decision
  • NXRT Hold
  • PAHC Hold
  • Analyst Count
  • NXRT 6
  • PAHC 4
  • Target Price
  • NXRT $41.88
  • PAHC $24.50
  • AVG Volume (30 Days)
  • NXRT 158.5K
  • PAHC 351.2K
  • Earning Date
  • NXRT 07-29-2025
  • PAHC 08-27-2025
  • Dividend Yield
  • NXRT 5.88%
  • PAHC 1.64%
  • EPS Growth
  • NXRT N/A
  • PAHC 140.17
  • EPS
  • NXRT N/A
  • PAHC 0.78
  • Revenue
  • NXRT $255,529,000.00
  • PAHC $1,190,682,000.00
  • Revenue This Year
  • NXRT N/A
  • PAHC $28.13
  • Revenue Next Year
  • NXRT $5.28
  • PAHC $13.11
  • P/E Ratio
  • NXRT N/A
  • PAHC $37.44
  • Revenue Growth
  • NXRT N/A
  • PAHC 19.12
  • 52 Week Low
  • NXRT $30.98
  • PAHC $16.16
  • 52 Week High
  • NXRT $48.37
  • PAHC $31.80
  • Technical
  • Relative Strength Index (RSI)
  • NXRT 55.99
  • PAHC 62.59
  • Support Level
  • NXRT $33.58
  • PAHC $28.75
  • Resistance Level
  • NXRT $34.88
  • PAHC $31.71
  • Average True Range (ATR)
  • NXRT 0.69
  • PAHC 1.02
  • MACD
  • NXRT 0.13
  • PAHC -0.24
  • Stochastic Oscillator
  • NXRT 83.83
  • PAHC 45.78

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: